Copyright Reports & Markets. All rights reserved.

Global Insomnia Therapeutics Drugs Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Insomnia Therapeutics Drugs Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Benzodiazepines
    • 1.4.3 Nonbenzodiazepines
    • 1.4.4 Antidepressants
    • 1.4.5 Orexin Antagonists
    • 1.4.6 Melatonin Antagonists
    • 1.4.7 Others
  • 1.5 Market by Application
    • 1.5.1 Global Insomnia Therapeutics Drugs Market Share by Application: 2020 VS 2026
    • 1.5.2 Prescription
    • 1.5.3 Over-the-Counter (OTC)
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Insomnia Therapeutics Drugs Market Perspective (2015-2026)
  • 2.2 Global Insomnia Therapeutics Drugs Growth Trends by Regions
    • 2.2.1 Insomnia Therapeutics Drugs Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Insomnia Therapeutics Drugs Historic Market Share by Regions (2015-2020)
    • 2.2.3 Insomnia Therapeutics Drugs Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Insomnia Therapeutics Drugs Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Insomnia Therapeutics Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Insomnia Therapeutics Drugs Players by Market Size
    • 3.1.1 Global Top Insomnia Therapeutics Drugs Players by Revenue (2015-2020)
    • 3.1.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Insomnia Therapeutics Drugs Market Concentration Ratio
    • 3.2.1 Global Insomnia Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Insomnia Therapeutics Drugs Revenue in 2019
  • 3.3 Insomnia Therapeutics Drugs Key Players Head office and Area Served
  • 3.4 Key Players Insomnia Therapeutics Drugs Product Solution and Service
  • 3.5 Date of Enter into Insomnia Therapeutics Drugs Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Insomnia Therapeutics Drugs Historic Market Size by Type (2015-2020)
  • 4.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Insomnia Therapeutics Drugs Market Size by Application (2015-2020)
  • 5.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Insomnia Therapeutics Drugs Market Size (2015-2020)
  • 6.2 Insomnia Therapeutics Drugs Key Players in North America (2019-2020)
  • 6.3 North America Insomnia Therapeutics Drugs Market Size by Type (2015-2020)
  • 6.4 North America Insomnia Therapeutics Drugs Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Insomnia Therapeutics Drugs Market Size (2015-2020)
  • 7.2 Insomnia Therapeutics Drugs Key Players in Europe (2019-2020)
  • 7.3 Europe Insomnia Therapeutics Drugs Market Size by Type (2015-2020)
  • 7.4 Europe Insomnia Therapeutics Drugs Market Size by Application (2015-2020)

8 China

  • 8.1 China Insomnia Therapeutics Drugs Market Size (2015-2020)
  • 8.2 Insomnia Therapeutics Drugs Key Players in China (2019-2020)
  • 8.3 China Insomnia Therapeutics Drugs Market Size by Type (2015-2020)
  • 8.4 China Insomnia Therapeutics Drugs Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Insomnia Therapeutics Drugs Market Size (2015-2020)
  • 9.2 Insomnia Therapeutics Drugs Key Players in Japan (2019-2020)
  • 9.3 Japan Insomnia Therapeutics Drugs Market Size by Type (2015-2020)
  • 9.4 Japan Insomnia Therapeutics Drugs Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Insomnia Therapeutics Drugs Market Size (2015-2020)
  • 10.2 Insomnia Therapeutics Drugs Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Insomnia Therapeutics Drugs Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Insomnia Therapeutics Drugs Market Size by Application (2015-2020)

11 India

  • 11.1 India Insomnia Therapeutics Drugs Market Size (2015-2020)
  • 11.2 Insomnia Therapeutics Drugs Key Players in India (2019-2020)
  • 11.3 India Insomnia Therapeutics Drugs Market Size by Type (2015-2020)
  • 11.4 India Insomnia Therapeutics Drugs Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Insomnia Therapeutics Drugs Market Size (2015-2020)
  • 12.2 Insomnia Therapeutics Drugs Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Insomnia Therapeutics Drugs Market Size by Type (2015-2020)
  • 12.4 Central & South America Insomnia Therapeutics Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Takeda Pharmaceutical Company Ltd.
    • 13.1.1 Takeda Pharmaceutical Company Ltd. Company Details
    • 13.1.2 Takeda Pharmaceutical Company Ltd. Business Overview
    • 13.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Introduction
    • 13.1.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2015-2020))
    • 13.1.5 Takeda Pharmaceutical Company Ltd. Recent Development
  • 13.2 Vanda Pharmaceuticals
    • 13.2.1 Vanda Pharmaceuticals Company Details
    • 13.2.2 Vanda Pharmaceuticals Business Overview
    • 13.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Introduction
    • 13.2.4 Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2015-2020)
    • 13.2.5 Vanda Pharmaceuticals Recent Development
  • 13.3 Merck & Co., Inc.
    • 13.3.1 Merck & Co., Inc. Company Details
    • 13.3.2 Merck & Co., Inc. Business Overview
    • 13.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Introduction
    • 13.3.4 Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2015-2020)
    • 13.3.5 Merck & Co., Inc. Recent Development
  • 13.4 Pfizer Inc.
    • 13.4.1 Pfizer Inc. Company Details
    • 13.4.2 Pfizer Inc. Business Overview
    • 13.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Introduction
    • 13.4.4 Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2015-2020)
    • 13.4.5 Pfizer Inc. Recent Development
  • 13.5 Teva Pharmaceutical Industries Ltd.
    • 13.5.1 Teva Pharmaceutical Industries Ltd. Company Details
    • 13.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
    • 13.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Introduction
    • 13.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2015-2020)
    • 13.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
  • 13.6 Mylan N.V.
    • 13.6.1 Mylan N.V. Company Details
    • 13.6.2 Mylan N.V. Business Overview
    • 13.6.3 Mylan N.V. Insomnia Therapeutics Drugs Introduction
    • 13.6.4 Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2015-2020)
    • 13.6.5 Mylan N.V. Recent Development
  • 13.7 Sumitomo Dainippon Pharma Co., Ltd
    • 13.7.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
    • 13.7.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
    • 13.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Introduction
    • 13.7.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2015-2020)
    • 13.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
  • 13.8 Sanofi
    • 13.8.1 Sanofi Company Details
    • 13.8.2 Sanofi Business Overview
    • 13.8.3 Sanofi Insomnia Therapeutics Drugs Introduction
    • 13.8.4 Sanofi Revenue in Insomnia Therapeutics Drugs Business (2015-2020)
    • 13.8.5 Sanofi Recent Development
  • 13.9 Paratek Pharmaceuticals Inc.
    • 13.9.1 Paratek Pharmaceuticals Inc. Company Details
    • 13.9.2 Paratek Pharmaceuticals Inc. Business Overview
    • 13.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Introduction
    • 13.9.4 Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2015-2020)
    • 13.9.5 Paratek Pharmaceuticals Inc. Recent Development
  • 13.10 Ebb Therapeutics
    • 13.10.1 Ebb Therapeutics Company Details
    • 13.10.2 Ebb Therapeutics Business Overview
    • 13.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Introduction
    • 13.10.4 Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2015-2020)
    • 13.10.5 Ebb Therapeutics Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Insomnia Therapeutics Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Insomnia Therapeutics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Takeda Pharmaceutical Company Ltd.
    Vanda Pharmaceuticals
    Merck & Co., Inc.
    Pfizer Inc.
    Teva Pharmaceutical Industries Ltd.
    Mylan N.V.
    Sumitomo Dainippon Pharma Co., Ltd
    Sanofi
    Paratek Pharmaceuticals Inc.
    Ebb Therapeutics

    Market segment by Type, the product can be split into
    Benzodiazepines
    Nonbenzodiazepines
    Antidepressants
    Orexin Antagonists
    Melatonin Antagonists
    Others
    Market segment by Application, split into
    Prescription
    Over-the-Counter (OTC)

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now